TRANSPAutologous Pulp Transplantation for Necrotic Mature Teeth with Periapical Radiolucency
This study aims to evaluate if using your own pulp for transplantation can restore vitality in mature teeth with necrotic tissue and periapical radiolucency.
Conventional root canal therapy
+ Autologous dental pulp transplantation
+ Pulp transplantation with CGF
Treatment Study
Summary
Study start date: November 5, 2023
Actual date on which the first participant was enrolled.This clinical study is exploring a new way to treat mature teeth that have become necrotic, which means the tooth's nerve tissue is dead, and there is an area of bone loss at the root's tip, known as periapical radiolucency. The research is focused on using a person's own dental pulp tissue, possibly combined with a concentrated growth factor, as a biologic alternative to traditional root canal treatments. This approach could help regenerate tissue and restore the function of these affected teeth. This study is important because it may offer a more natural and potentially more effective option for dental patients with this specific problem. Participants in this study are adults with single-rooted teeth that have been diagnosed with pulp necrosis and periapical issues. They are randomly assigned to one of three treatment groups: one receiving only pulp transplantation, another receiving pulp transplantation plus a growth factor, and the third undergoing a standard root canal. The pulp tissue for transplantation is carefully taken from the patient's own non-damaged wisdom teeth. Throughout the study, the success of the treatments is measured by checking the vitality of the pulp using an electric pulp test and through X-ray images at various follow-up times. This study aims to gather essential evidence on whether these new methods are safe and effective for future dental treatments.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.21 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorGroup III
Active ComparatorStudy Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
ahramanmaraş Sütçü İmam University, Faculty of Dentistry
Kahramanmaraş, Turkey (Türkiye)Open ahramanmaraş Sütçü İmam University, Faculty of Dentistry in Google Maps